Viewing Study NCT06310161



Ignite Creation Date: 2024-05-06 @ 8:16 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06310161
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-23
First Post: 2024-01-02

Brief Title: Light Therapy in End Stage Kidney Disease
Sponsor: University of Pennsylvania
Organization: University of Pennsylvania

Study Overview

Official Title: Bright Light Therapy to Treat Fatigue in End Stage Kidney Disease
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis The main aim is to determine if light therapy decreases fatigue severity Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment
Detailed Description: In a single site 2-arm Bright Light Therapy group Dim Light Group parallel randomized controlled trial we will enroll 60 subjects n30 per group to assess the effects of Bright Light Therapy compared to Dim Light Therapy in subjects with end stage kidney disease who are receiving hemodialysis to treat fatigue

To compare the effects of bright light therapy to dim light therapy on fatigue severity
To explore the effects of bright light therapy to dim light therapy on salivary cortisol
To compare the effects of bright light therapy to dim light therapy on insomnia depression and quality of life
To test the effects on bright light therapy to dim light therapy on physical activity levels

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None